Table 2.
Tissue | Methodology | Sample size | Genes analyzed | Difference observed | Reference |
---|---|---|---|---|---|
Cord blood and placenta | GoldenGate array and RT-PCR | 10 ART, 13 in vivo | 736 genes | Yes | Katari et al. 2009 |
Placenta | Bisulfite PCR | 78 ART, 38 in vivo | H19, GTL2, PEG1, KCNQ1OT1, ZAC, PEG3, SNRPN, XIST | Yes | Kobayashi et al. 2009 |
Cord blood, peripheral blood, amnion/chorion | Bisulfite PCR | 77 ICSI, 35 IVF, 73 in vivo | KvDMR1, H19, SNRPN, MEST, GRB10, MEG3, IG-DMR, GNAS, NESP55, GNAS, NESPas, GNAS XL α-s, GNAS Exon1A | No | Tierling et al. 2010 |
Cord blood and placenta | Methylation specific-PCR and RT-PCR | 45 ART, 56 in vivo | IGF2/H19 and IGF2R DMR, X-inactivation | Yes | Turan et al. 2010 |
Placenta | RT-PCR | 65 ART, 924 in vivo | IGF2, H19, KCNQ1OT1, CDKN1C | Yes | Katagiri et al. 2010 |
Placenta (CVS) | Bisulfite PCR | 42 ART, 29 in vivo | H19, MEG3, LIT1, MEST, NESP55, PEG3, SNRPN, NANOG, APC | Yes | Zechner et al. 2010 |
Cord Blood | Bisulfite PCR, cloning and sequencing | 29 IVF and 30 in vivo conceived twin pairs | KvDMR1, PEG1, H19/IGF2 DMR | No | Li et al. 2011 |
Cord blood and peripheral blood | Bisulfite sequencing | 30 IVF, 30 ICSI and 60 in vivo | PEG3, L3MBTL, PHILDA2 | No | Feng et al. 2011 |
Placenta | Pyrosequencing | 35 IVF, 35 in vivo | H19, MEST | Yes | Nelissen et al. 2013 |
Chorionic villi and muscle samples | Pyrosequencing, bisulfite sequencing PCR | 75 ART stillbirth, 73 ART multifetal reduction, 90 natural conception stillbirths, 82 natural conception induced abortion | H19, LIT1, SNRPN | Yes | Zheng et al. 2013 |
Modified from data in Batcheller et al. (2011).